Neriifolin from seeds of Cerbera manghas L. induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells

Fitoterapia

Volumn 82, Issue 5, 2011, Pages 735-741

  Zhao, Qian ^a   Guo, Yuewei ^b   Feng, Bo ^a   Li, Liang ^b   Huang, Caiguo ^a   Jiao, Binghua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apoptosis; Caspases; Cell cycle arrest; Fas; FasL; HepG2

Indexed keywords

CARDIAC GLYCOSIDE; CASPASE 3; CASPASE 8; CASPASE 9; FAS ANTIGEN; FAS LIGAND; NERIIFOLIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CERBERA MANGHAS; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CELL CARCINOMA; MEDICINAL PLANT; PLANT SEED; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOCYNACEAE; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CARDENOLIDES; CASPASES; CELL CYCLE; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; SEEDS; UP-REGULATION;

CERBERA MANGHAS;

EID: 79957764101     PISSN: 0367326X     EISSN: 0367326X     Source Type: Journal    
DOI: 10.1016/j.fitote.2011.03.004     Document Type: Article

References (43)

1. Norton TR, Bristol ML, Read GW, Bushnell OA, Kashiwagi M, Okinaga CM, et al. Pharmacological evaluation of medicinal plants from Western Samoa. J Pharm Sci 1973;62:1077.
2. Hien TT, Navarro-Delmasure C, Vy T. Toxicity and effects on the central nervous system of a Cerbera odollam leaf extract. J Ethnopharmacol 1991;34:201.
3. Abe F, Yamauchi T. Studies on Cerbera. I. Cardiac glycosides in the seeds, bark, and leaves of Cerbera manghas L. Chem Pharm Bull (Tokyo) 1977;25:2744.
4. Braunwald E. Effects of digitalis on the normal and the failing heart. J Am Coll Cardiol 1985;5:51A.
5. Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 2006;27:178.
6. Brophy JM. Rehabilitating digoxin. Eur Heart J 2006;27:127.
7. Stenkvist B. Cardenolides and cancer. Anti-cancer Drugs 2001;12:635.
8. Trevisi L, Visentin B, Cusinato F, Pighin I, Luciani S. Antiapoptotic effect of ouabain on human umbilical vein endothelial cells. Biochem Biophys Res Commun 2004;321:716.
9. Li J, Zelenin S, Aperia A, Aizman O. Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kappaB. J Am Soc Nephrol 2006;17:1848.
10. Matsuda Y, Ichida T, Genda T, Yamagiwa S, Aoyagi Y, Asakura H. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma. Clin Cancer Res 2003;9:3389.
11. Masaki T, Shiratori Y, Rengifo W, Igarashi K, Matsumoto K, Nishioka M, et al. Hepatocellular carcinoma cell cycle: study of Long-Evans cinnamon rats. Hepatology 2000;32:711.
12. Masaki T, Shiratori Y, Rengifo W, Igarashi K, Yamagata M, Kurokohchi K, et al. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 2003;37:534.
13. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770.
14. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301.
15. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233.
16. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169.
17. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995;270:7795.
18. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999;17:331.
19. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999;341(Pt 2):233.
20. Gottlieb RA. Mitochondria: execution central. FEBS Lett 2000;482:6.
21. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479.
22. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441.
23. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000;6:513.
24. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17:1675.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55.
26. Han YW, Kim SZ, Kim SH, Park WH. The changes of intracellular H2O2 are an important factor maintaining mitochondria membrane potential of antimycin A-treated As4.1 juxtaglomerular cells. Biochem Pharmacol 2007;73:863.
27. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 2007;293:C509.
28. Newman RA, Yang P, Pawlus AD, Block KI. Cardiac glycosides as novel cancer therapeutic agents. Mol Interv 2008;8:36.
29. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997;91:443.
30. Schempp CM, Simon-Haarhaus B, Termeer CC, Simon JC. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8. FEBS Lett 2001;493:26.
31. Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci USA 1999;96:10964.
32. Friesen C, Herr I, Krammer PH, Debatin KM. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 1996;2:574.
33. Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H. Upregulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res 1998;58:2057.
34. Tillman DM, Petak I, Houghton JA. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells. Clin Cancer Res 1999;5:425.
35. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997;57:3823.
36. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 1997;99:403.
37. Meier P, Finch A, Evan G. Apoptosis in development. Nature 2000;407:796.
38. Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev 2005;5:876.
39. Fulda S. Apoptosis pathways and their therapeutic exploitation in pancreatic cancer. J Cell Mol Med 2009;13:1221.
40. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57.
41. Smets LA. Programmed cell death (apoptosis) and response to anticancer drugs. Anti-cancer Drugs 1994;5:3.
42. Gata-Goncalves L, Nogueira JM, Matos O, Bruno de Sousa R. Photoactive extracts from Thevetia peruviana with antifungal properties against Cladosporium cucumerinum. J Photochem Photobiol 2003;70:51.
43. Bandara V, Weinstein SA, White J, Eddleston M. A review of the natural history, toxinology, diagnosis and clinical management of Nerium oleander (common oleander) and Thevetia peruviana (yellow oleander) poisoning. Toxicon 2010;56:273.